Niklas Landberg, Sofia von Palffy, Maria Askmyr, Henrik Lilljebjörn, Carl Sandén, Marianne Rissler, Satu Mustjoki, Henrik Hjorth-Hansen, Johan Richter, Helena Ågerstam, Marcus Järås, and Thoas Fioretos. 2018. “CD36 Defines Primitive Chronic Myeloid Leukemia Cells Less Responsive to Imatinib But Vulnerable to Antibody-Based Therapeutic Targeting”. Haematologica 103 (3). Pavia, Italy, 447-55. https://doi.org/10.3324/haematol.2017.169946.